Diabetes

Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market

Published in Lab Business Week, October 21st, 2007

Carrington Laboratories, Inc. (Pink Sheets: CARN) announced it has formalized its previously announced multi-year supply and distribution term sheet with DaySpring Pharma, LLC (http://www.dayspringpharma.com/). The previous announcement included a two-year term; the final, formal agreement has been extended to five years.

Under the terms of this agreement, Carrington will supply multiple prescription products based on Carrington's flagship DiaB(TM) and Radia(TM) brands to DaySpring for distribution into the physician market. Carrington's DiaB(TM) and Radia(TM) products have been developed specifically for diabetic wound care and for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-10-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry